HPV in Adolescents

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

27 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-12-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will assess the prevalence of HPV infection in perinatally HIV-infected adolescents, intraepithelial neoplasia, and E6E7 biomarker at cervical and anal sites.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

HPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective Study

NCT01792973

Cervical Cancer

COMPLETED

Long Term Follow-up of HPV Vaccine in HIV (CTN 236)

NCT06915779

Cervical Cancer Human Papillomavirus Infection Human Immunodeficiency Virus +2 more

COMPLETED

Biomarkers to Detect Anal Intraepithelial Neoplasia in Thai Men Who Have Sex With Men

NCT01637298

Anal Intraepithelial Neoplasia

COMPLETED

HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population

NCT05981807

Human Papillomavirus Infection Human Immunodeficiency Virus Infection Sexually Transmitted Diseases

UNKNOWN

Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study

NCT05065840

Human Papilloma Virus Human Papilloma Virus Vaccine

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Human Papillomavirus (HPV) is the most common sexually transmitted disease and it causes cervical and anal cancer. Prevalence and incidence of HPV infection among young adults who are sexually experienced is high. No data exist for HIV-positive adolescents in regards to HPV infection, cervical and anal intraepithelial neoplasia. This study will compare the prevalence of HPV infection, intraepithelial neoplasia and E6/E7 biomarker at cervical and anal sites among perinatally HIV-infected adolescents, behaviorally HIV-infected adolescents, and HIV-negative adolescents.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HPV Infection Cervical/Anal Dysplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Perinatally HIV-infected adolescents

No interventions assigned to this group

behaviorally HIV-infected adolescents

No interventions assigned to this group

HIV negative adolescents

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Perinatally-infected (documented positive HIV enzyme immunoassay (EIA) or nucleic acid testing (NAT) at any time and history of maternal HIV infection)
* behaviorally-infected (documented positive HIV enzyme immunoassay (EIA) or nucleic acid testing (NAT) at any time after sexual debut without history of maternal HIV infection)
* female with vaginal or receptive anal intercourse with a male OR male with receptive rectal intercourse with another male
* Signed informed consent. Volunteers aged 12-17 years can decide whether they wish for their parents to consent for their participation. Due to the confidential nature of the issues being studied, parental consent may be exempted